-
1
-
-
0035796487
-
Anuria, omphalocele, and perinatal lethality in mice lacking the CD34-related protein podocalyxin
-
Doyonnas R, Kershaw DB, Duhme C, Merkens H, Chelliah S, Graf T, McNagny KM: Anuria, omphalocele, and perinatal lethality in mice lacking the CD34-related protein podocalyxin. J Exp Med 2001, 194:13-27
-
(2001)
J Exp Med
, vol.194
, pp. 13-27
-
-
Doyonnas, R.1
Kershaw, D.B.2
Duhme, C.3
Merkens, H.4
Chelliah, S.5
Graf, T.6
McNagny, K.M.7
-
2
-
-
0034492323
-
Expression of podocalyxin inhibits cell-cell adhesion and modifies junctional properties in Madin-Darby canine kidney cells
-
Takeda T, Go WY, Orlando RA, Farquhar MG: Expression of podocalyxin inhibits cell-cell adhesion and modifies junctional properties in Madin-Darby canine kidney cells. Mol Biol Cell 2000, 11:3219-3232 (Pubitemid 32107095)
-
(2000)
Molecular Biology of the Cell
, vol.11
, Issue.9
, pp. 3219-3232
-
-
Takeda, T.1
Go, W.Y.2
Orlando, R.A.3
Farquhar, M.G.4
-
3
-
-
0035856480
-
WT1 regulates the expression of the major glomerular podocyte membrane protein Podocalyxin
-
Palmer RE, Kotsianti A, Cadman B, Boyd T, Gerald W, Haber DA: WT1 regulates the expression of the major glomerular podocyte membrane protein Podocalyxin. Curr Biol 2001, 11:1805-1809
-
(2001)
Curr Biol
, vol.11
, pp. 1805-1809
-
-
Palmer, R.E.1
Kotsianti, A.2
Cadman, B.3
Boyd, T.4
Gerald, W.5
Haber, D.A.6
-
4
-
-
4043128192
-
The Wilms tumor suppressor-1 target gene podocalyxin is transcriptionally repressed by p53
-
Stanhope-Baker P, Kessler PM, Li W, Agarwal ML, Williams BR: The Wilms tumor suppressor-1 target gene podocalyxin is transcriptionally repressed by p53. J Biol Chem 2004, 279:33575-33585
-
(2004)
J Biol Chem
, vol.279
, pp. 33575-33585
-
-
Stanhope-Baker, P.1
Kessler, P.M.2
Li, W.3
Agarwal, M.L.4
Williams, B.R.5
-
5
-
-
14544282007
-
Mouse ovary developmental RNA and protein markers from gene expression profiling
-
Herrera L, Ottolenghi C, Garcia-Ortiz JE, Pellegrini M, Manini F, Ko MS, Nagaraja R, Forabosco A, Schlessinger D: Mouse ovary developmental RNA and protein markers from gene expression profiling. Dev Biol 2005, 279:271-290
-
(2005)
Dev Biol
, vol.279
, pp. 271-290
-
-
Herrera, L.1
Ottolenghi, C.2
Garcia-Ortiz, J.E.3
Pellegrini, M.4
Manini, F.5
Ko, M.S.6
Nagaraja, R.7
Forabosco, A.8
Schlessinger, D.9
-
6
-
-
12344315918
-
Pattern of expression of the podocalyxin gene in the mouse brain during development
-
Vitureira N, McNagny K, Soriano E, Burgaya F: Pattern of expression of the podocalyxin gene in the mouse brain during development. Gene Expr Patterns 2005, 5:349-354
-
(2005)
Gene Expr Patterns
, vol.5
, pp. 349-354
-
-
Vitureira, N.1
McNagny, K.2
Soriano, E.3
Burgaya, F.4
-
7
-
-
33847707437
-
Pleomorphic extra-renal manifestation of the glomerular podocyte marker podocalyxin in tissues of normal beagle dogs
-
Lin WL, Pang VF, Liu CH, Chen JY, Shen KF, Lin YY, Yu CY, Hsu YH, Jou TS: Pleomorphic extra-renal manifestation of the glomerular podocyte marker podocalyxin in tissues of normal beagle dogs. Histochem Cell Biol 2007, 127:399-414
-
(2007)
Histochem Cell Biol
, vol.127
, pp. 399-414
-
-
Lin, W.L.1
Pang, V.F.2
Liu, C.H.3
Chen, J.Y.4
Shen, K.F.5
Lin, Y.Y.6
Yu, C.Y.7
Hsu, Y.H.8
Jou, T.S.9
-
8
-
-
19344367487
-
Podocalyxin is a CD34-related marker of murine hematopoietic stem cells and embryonic erythroid cells
-
Doyonnas R, Nielsen JS, Chelliah S, Drew E, Hara T, Miyajima A, McNagny KM: Podocalyxin is a CD34-related marker of murine hematopoietic stem cells and embryonic erythroid cells. Blood 2005, 105:4170-4178
-
(2005)
Blood
, vol.105
, pp. 4170-4178
-
-
Doyonnas, R.1
Nielsen, J.S.2
Chelliah, S.3
Drew, E.4
Hara, T.5
Miyajima, A.6
McNagny, K.M.7
-
9
-
-
3442882797
-
Overexpression of the anti-adhesin podocalyxin is an independent predictor of breast cancer progression
-
Somasiri A, Nielsen JS, Makretsov N, McCoy ML, Prentice L, Gilks CB, Chia SK, Gelmon KA, Kershaw DB, Huntsman DG, McNagny KM, Roskelley CD: Overexpression of the anti-adhesin podocalyxin is an independent predictor of breast cancer progression. Cancer Res 2004, 64:5068-5073
-
(2004)
Cancer Res
, vol.64
, pp. 5068-5073
-
-
Somasiri, A.1
Nielsen, J.S.2
Makretsov, N.3
McCoy, M.L.4
Prentice, L.5
Gilks, C.B.6
Chia, S.K.7
Gelmon, K.A.8
Kershaw, D.B.9
Huntsman, D.G.10
McNagny, K.M.11
Roskelley, C.D.12
-
10
-
-
33144489248
-
Podocalyxin variants and risk of prostate cancer and tumor aggressiveness
-
Casey G, Neville PJ, Liu X, Plummer SJ, Cicek MS, Krumroy LM, Curran AP, McGreevy MR, Catalona WJ, Klein EA, Witte JS: Podocalyxin variants and risk of prostate cancer and tumor aggressiveness. Hum Mol Genet 2006, 15:735-741
-
(2006)
Hum Mol Genet
, vol.15
, pp. 735-741
-
-
Casey, G.1
Neville, P.J.2
Liu, X.3
Plummer, S.J.4
Cicek, M.S.5
Krumroy, L.M.6
Curran, A.P.7
McGreevy, M.R.8
Catalona, W.J.9
Klein, E.A.10
Witte, J.S.11
-
11
-
-
33750843697
-
Podocalyxin is expressed in normal and leukemic monocytes
-
Riccioni R, Calzolari A, Biffoni M, Senese M, Riti V, Petrucci E, Pasquini L, Cedrone M, Lo-Coco F, Diverio D, Foa R, Peschle C, Testa U: Podocalyxin is expressed in normal and leukemic monocytes. Blood Cells Mol Dis 2006, 37:218-225
-
(2006)
Blood Cells Mol Dis
, vol.37
, pp. 218-225
-
-
Riccioni, R.1
Calzolari, A.2
Biffoni, M.3
Senese, M.4
Riti, V.5
Petrucci, E.6
Pasquini, L.7
Cedrone, M.8
Lo-Coco, F.9
Diverio, D.10
Foa, R.11
Peschle, C.12
Testa, U.13
-
12
-
-
21744441931
-
Podocalyxin: A marker of blasts in acute leukemia
-
Kelley TW, Huntsman D, McNagny KM, Roskelley CD, Hsi ED: Podocalyxin: a marker of blasts in acute leukemia. Am J Clin Pathol 2005, 124:134-142
-
(2005)
Am J Clin Pathol
, vol.124
, pp. 134-142
-
-
Kelley, T.W.1
Huntsman, D.2
McNagny, K.M.3
Roskelley, C.D.4
Hsi, E.D.5
-
13
-
-
56049089631
-
Podocalyxin expression in undifferentiated thyroid carcinomas
-
Yasuoka H, Tsujimoto M, Hirokawa M, Tori M, Nakahara M, Miyauchi A, Kodama R, Sanke T, Nakamura Y: Podocalyxin expression in undifferentiated thyroid carcinomas. J Clin Pathol 2008, 61:1228-1229
-
(2008)
J Clin Pathol
, vol.61
, pp. 1228-1229
-
-
Yasuoka, H.1
Tsujimoto, M.2
Hirokawa, M.3
Tori, M.4
Nakahara, M.5
Miyauchi, A.6
Kodama, R.7
Sanke, T.8
Nakamura, Y.9
-
14
-
-
33747395161
-
Podocalyxin-like protein 1 expression in primary hepatic tumours and tumour-like lesions
-
Heukamp LC, Fischer HP, Schirmacher P, Chen X, Breuhahn K, Nicolay C, Buttner R, Gutgemann I: Podocalyxin-like protein 1 expression in primary hepatic tumours and tumour-like lesions. Histopathology 2006, 49:242-247
-
(2006)
Histopathology
, vol.49
, pp. 242-247
-
-
Heukamp, L.C.1
Fischer, H.P.2
Schirmacher, P.3
Chen, X.4
Breuhahn, K.5
Nicolay, C.6
Buttner, R.7
Gutgemann, I.8
-
15
-
-
26944476343
-
Molecular identification of canine podocalyxin-like protein 1 as a renal tubulogenic regulator
-
Cheng HY, Lin YY, Yu CY, Chen JY, Shen KF, Lin WL, Liao HK, Chen YJ, Liu CH, Pang VF, Jou TS: Molecular identification of canine podocalyxin-like protein 1 as a renal tubulogenic regulator. J Am Soc Nephrol 2005, 16:1612-1622
-
(2005)
J Am Soc Nephrol
, vol.16
, pp. 1612-1622
-
-
Cheng, H.Y.1
Lin, Y.Y.2
Yu, C.Y.3
Chen, J.Y.4
Shen, K.F.5
Lin, W.L.6
Liao, H.K.7
Chen, Y.J.8
Liu, C.H.9
Pang, V.F.10
Jou, T.S.11
-
16
-
-
0035040115
-
The GTPase Rac1 selectively regulates Salmonella invasion at the apical plasma membrane of polarized epithelial cells
-
Criss AK, Ahlgren DM, Jou TS, McCormick BA, Casanova JE: The GTPase Rac1 selectively regulates Salmonella invasion at the apical plasma membrane of polarized epithelial cells. J Cell Sci 2001, 114:1331-1341
-
(2001)
J Cell Sci
, vol.114
, pp. 1331-1341
-
-
Criss, A.K.1
Ahlgren, D.M.2
Jou, T.S.3
McCormick, B.A.4
Casanova, J.E.5
-
17
-
-
0017758251
-
Functional correlation between cell adhesive properties and some cell surface proteins
-
Takeichi M: Functional correlation between cell adhesive properties and some cell surface proteins. J Cell Biol 1977, 75:464-474
-
(1977)
J Cell Biol
, vol.75
, pp. 464-474
-
-
Takeichi, M.1
-
18
-
-
0032514214
-
Effects of regulated expression of mutant RhoA and Rac1 small GTPases on the development of epithelial (MDCK) cell polarity
-
Jou TS, Nelson WJ: Effects of regulated expression of mutant RhoA and Rac1 small GTPases on the development of epithelial (MDCK) cell polarity. J Cell Biol 1998, 142:85-100
-
(1998)
J Cell Biol
, vol.142
, pp. 85-100
-
-
Jou, T.S.1
Nelson, W.J.2
-
19
-
-
33751252276
-
Cancer metastasis: Building a framework
-
Gupta GP, Massague J: Cancer metastasis: building a framework. Cell 2006, 127:679-695
-
(2006)
Cell
, vol.127
, pp. 679-695
-
-
Gupta, G.P.1
Massague, J.2
-
20
-
-
33746851956
-
Tumor metastasis: Mechanistic insights and clinical challenges
-
Steeg PS: Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 2006, 12:895-904
-
(2006)
Nat Med
, vol.12
, pp. 895-904
-
-
Steeg, P.S.1
-
21
-
-
0029079431
-
A role for Rac in Tiam1-induced membrane ruffling and invasion
-
Michiels F, Habets GG, Stam JC, van der Kammen RA, Collard JG: A role for Rac in Tiam1-induced membrane ruffling and invasion. Nature 1995, 375:338-340
-
(1995)
Nature
, vol.375
, pp. 338-340
-
-
Michiels, F.1
Habets, G.G.2
Stam, J.C.3
Van Der Kammen, R.A.4
Collard, J.G.5
-
22
-
-
0031459917
-
Cdc42 and Rac1 induce integrin-mediated cell motility and invasiveness through PI(3)K
-
Keely PJ, Westwick JK, Whitehead IP, Der CJ, Parise LV: Cdc42 and Rac1 induce integrin-mediated cell motility and invasiveness through PI(3)K. Nature 1997, 390:632-636
-
(1997)
Nature
, vol.390
, pp. 632-636
-
-
Keely, P.J.1
Westwick, J.K.2
Whitehead, I.P.3
Der, C.J.4
Parise, L.V.5
-
23
-
-
4344716629
-
Podocalyxin activates RhoA and induces actin reorganization through NHERF1 and Ezrin in MDCK cells
-
Schmieder S, Nagai M, Orlando RA, Takeda T, Farquhar MG: Podocalyxin activates RhoA and induces actin reorganization through NHERF1 and Ezrin in MDCK cells. J Am Soc Nephrol 2004, 15:2289-2298
-
(2004)
J Am Soc Nephrol
, vol.15
, pp. 2289-2298
-
-
Schmieder, S.1
Nagai, M.2
Orlando, R.A.3
Takeda, T.4
Farquhar, M.G.5
-
24
-
-
34447119556
-
Podocalyxin increases the aggressive phenotype of breast and prostate cancer cells in vitro through its interaction with ezrin
-
Sizemore S, Cicek M, Sizemore N, Ng KP, Casey G: Podocalyxin increases the aggressive phenotype of breast and prostate cancer cells in vitro through its interaction with ezrin. Cancer Res 2007, 67:6183-6191
-
(2007)
Cancer Res
, vol.67
, pp. 6183-6191
-
-
Sizemore, S.1
Cicek, M.2
Sizemore, N.3
Ng, K.P.4
Casey, G.5
-
25
-
-
0030846295
-
Direct interaction of the Rho GDP dissociation inhibitor with ezrin/radixin/moesin initiates the activation of the Rho small G protein
-
Takahashi K, Sasaki T, Mammoto A, Takaishi K, Kameyama T, Tsukita S, Takai Y: Direct interaction of the Rho GDP dissociation inhibitor with ezrin/radixin/moesin initiates the activation of the Rho small G protein. J Biol Chem 1997, 272:23371-23375
-
(1997)
J Biol Chem
, vol.272
, pp. 23371-23375
-
-
Takahashi, K.1
Sasaki, T.2
Mammoto, A.3
Takaishi, K.4
Kameyama, T.5
Tsukita, S.6
Takai, Y.7
-
26
-
-
0036308458
-
Lipid products of PI(3)Ks maintain persistent cell polarity and directed motility in neutrophils
-
Wang F, Herzmark P, Weiner OD, Srinivasan S, Servant G, Bourne HR: Lipid products of PI(3)Ks maintain persistent cell polarity and directed motility in neutrophils. Nat Cell Biol 2002, 4:513-518
-
(2002)
Nat Cell Biol
, vol.4
, pp. 513-518
-
-
Wang, F.1
Herzmark, P.2
Weiner, O.D.3
Srinivasan, S.4
Servant, G.5
Bourne, H.R.6
-
27
-
-
0036308972
-
A PtdInsP(3)- And Rho GTPase-mediated positive feedback loop regulates neutrophil polarity
-
Weiner OD, Neilsen PO, Prestwich GD, Kirschner MW, Cantley LC, Bourne HR: A PtdInsP(3)- and Rho GTPase-mediated positive feedback loop regulates neutrophil polarity. Nat Cell Biol 2002, 4:509-513
-
(2002)
Nat Cell Biol
, vol.4
, pp. 509-513
-
-
Weiner, O.D.1
Neilsen, P.O.2
Prestwich, G.D.3
Kirschner, M.W.4
Cantley, L.C.5
Bourne, H.R.6
-
29
-
-
0038121958
-
EBP50, a beta-catenin-associating protein, enhances Wnt signaling and is over-expressed in hepatocellular carcinoma
-
Shibata T, Chuma M, Kokubu A, Sakamoto M, Hirohashi S: EBP50, a beta-catenin-associating protein, enhances Wnt signaling and is over-expressed in hepatocellular carcinoma. Hepatology 2003, 38: 178-186
-
(2003)
Hepatology
, vol.38
, pp. 178-186
-
-
Shibata, T.1
Chuma, M.2
Kokubu, A.3
Sakamoto, M.4
Hirohashi, S.5
-
30
-
-
33845509277
-
Suppression of breast cancer cell growth by Na+/H+ exchanger regulatory factor 1 (NHERF1)
-
Pan Y, Wang L, Dai JL: Suppression of breast cancer cell growth by Na+/H+ exchanger regulatory factor 1 (NHERF1). Breast Cancer Res 2006, 8:R63
-
(2006)
Breast Cancer Res
, vol.8
-
-
Pan, Y.1
Wang, L.2
Dai, J.L.3
-
31
-
-
34547750009
-
Cortical stabilization of betacatenin contributes to NHERF1/EBP50 tumor suppressor function
-
Kreimann EL, Morales FC, de Orbeta-Cruz J, Takahashi Y, Adams H, Liu TJ, McCrea PD, Georgescu MM: Cortical stabilization of betacatenin contributes to NHERF1/EBP50 tumor suppressor function. Oncogene 2007, 26:5290-5299
-
(2007)
Oncogene
, vol.26
, pp. 5290-5299
-
-
Kreimann, E.L.1
Morales, F.C.2
De Orbeta-Cruz, J.3
Takahashi, Y.4
Adams, H.5
Liu, T.J.6
McCrea, P.D.7
Georgescu, M.M.8
-
32
-
-
34250846034
-
Expression and clinicopathological significance of oestrogen-responsive ezrin-radixin-moesin-binding phosphoprotein 50 in breast cancer
-
Song J, Bai J, Yang W, Gabrielson EW, Chan DW, Zhang Z: Expression and clinicopathological significance of oestrogen-responsive ezrin-radixin-moesin- binding phosphoprotein 50 in breast cancer. Histopathology 2007, 51:40-53
-
(2007)
Histopathology
, vol.51
, pp. 40-53
-
-
Song, J.1
Bai, J.2
Yang, W.3
Gabrielson, E.W.4
Chan, D.W.5
Zhang, Z.6
|